| 1 |
34582053 | X-Linked Dystonia-Parkinsonism ("Lubag") May Present with Peripheral Synucleinopathy. | 2022 Jan |
1 |
| 2 |
35508570 | Marked response to levodopa in a patient with multiple system atrophy presenting with orthostatic hypotension: should reduced DAT uptake on DaTSCAN be a criterion for response to levodopa? | 2022 May 5 |
2 |
| 3 |
33962918 | Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism. | 2021 May 7 |
1 |
| 4 |
34284020 | l-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter. | 2021 Oct 1 |
1 |
| 5 |
32520511 | The Correlation of Salivary Gland Uptake Between 18F-FP-CIT PET/CT and Salivary Scan. | 2020 Aug |
1 |
| 6 |
30316985 | DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease. | 2019 Jan 18 |
3 |
| 7 |
30353564 | The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease. | 2019 Feb |
5 |
| 8 |
29406893 | Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation. | 2018 Feb 15 |
1 |
| 9 |
29185545 | Movement disorders and chronic psychosis: Five new things. | 2017 Apr |
1 |
| 10 |
26642370 | Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies. | 2016 |
3 |
| 11 |
27190169 | Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials. | 2016 Jun |
2 |
| 12 |
27498816 | A case of Parkinson's disease following dystonia. | 2016 Sep 29 |
1 |
| 13 |
25805645 | Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease. | 2015 May |
4 |
| 14 |
26253444 | Putaminal serotonergic innervation: monitoring dyskinesia risk in Parkinson disease. | 2015 Sep 8 |
1 |
| 15 |
26253446 | Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia. | 2015 Sep 8 |
1 |
| 16 |
26516604 | Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion. | 2015 |
1 |
| 17 |
24369987 | Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. | 2014 Feb |
2 |
| 18 |
24614670 | Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 gene. | 2014 Mar-Apr |
2 |
| 19 |
24633632 | Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease. | 2014 Jun |
2 |
| 20 |
23363854 | Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease. | 2013 Jul |
4 |
| 21 |
23631981 | Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry. | 2013 Oct 1 |
2 |
| 22 |
23861813 | DAT1 polymorphism determines L-DOPA effects on learning about others' prosociality. | 2013 |
1 |
| 23 |
22531611 | The relationship between cerebral vascular disease and parkinsonism: The VADO study. | 2012 Jul |
1 |
| 24 |
22001994 | Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease. | 2011 |
1 |
| 25 |
20199208 | Complementary acupuncture in Parkinson's disease: a spect study. | 2010 Feb |
2 |
| 26 |
20457180 | Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis. | 2010 Aug |
2 |
| 27 |
20887875 | Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications. | 2010 |
2 |
| 28 |
21124922 | Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys. | 2010 Nov 22 |
1 |
| 29 |
17027115 | [Camptocormia disclosing Parkinson's disease]. | 2007 Jan |
1 |
| 30 |
15936832 | The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? | 2005 Jul |
1 |
| 31 |
16151764 | The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease. | 2005 Dec |
3 |
| 32 |
16222436 | Does levodopa slow or hasten the rate of progression of Parkinson's disease? | 2005 Oct |
1 |
| 33 |
12796525 | L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. | 2003 Jun 10 |
4 |
| 34 |
12480442 | Dopamine agonist monotherapy in Parkinson's disease. | 2002 Nov 30 |
1 |
| 35 |
11402115 | Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. | 2001 Jun 12 |
4 |
| 36 |
10995853 | Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain. | 2000 Sep 15 |
2 |
| 37 |
11072750 | Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT. | 2000 |
1 |
| 38 |
11083235 | Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study. | 2000 Nov |
2 |
| 39 |
10086151 | [Drug therapy in Parkinson's disease]. | 1999 Jan 30 |
1 |
| 40 |
10214747 | PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease. | 1999 Apr 12 |
1 |
| 41 |
10348466 | Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT. | 1999 May |
2 |
| 42 |
9191769 | [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold. | 1997 Jun |
1 |